| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |